- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-Q Quarterly report
- 31.1 Certification of Elazar Rabbani, PH.D. Pursuant to Section 302 of the Sarbanes-oxley Act of 2002.
- 31.2 Certification of David Bench Pursuant to Section 302 of the Sarbanes-oxley Act of 2002.
- 32.1 Certification of Elazar Rabbani, PH.D
- 32.2 Certification of David Bench
- Download Excel data file
- View Excel data file
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
TITLE 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Enzo Biochem, Inc., and Subsidiaries (“the Company”) on Form 10-Q for the period ended January 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David Bench, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 16, 2021
By: | /s/ David Bench | |
David Bench | ||
Chief Financial Officer and Principal Accounting Officer |